Abstract

Background

The skin is both a target and a potential conduit for the delivery of drugs, but its cornified cell layer resists penetration by most molecules. This study investigated the potential of superparamagnetic iron oxide nanoparticles to facilitate the transdermal delivery of anticancer agents.

Results

Chemotherapeutic cancer drugs were applied with or without nanoparticles to the skin of hairless mice, and their ability to penetrate the skin was assessed using fluorescence microscopy and tumor growth. Nanoparticles enhanced the penetration of the skin by doxorubicin and 5-fluorouracil as determined by fluorescence microscopy and growth retardation of experimental melanoma in immunocompetent, syngeneic mice. This drug enhancement did not require conjugation or encapsulation of the drugs by the nanoparticles—simple co-administration sufficed. Nanoparticles applied topically to melanomas increased the cytotoxicity and immune cell infiltration induced by co-administered 5-fluorouracil, and also reduced vascularization of the tumors independently of 5-fluorouracil.

Conclusion

Correctly formulated superparamagnetic iron oxide nanoparticles can facilitate the chemotherapeutic effectiveness of cytotoxic drugs on skin tumors by both increasing their transdermal penetration and ameliorating host–tumor interactions. This enhancement of skin penetration occurs without the need for conjugation or encapsulation of the co-administered drugs, and so will likely be applicable to other drugs, also.

Details

Title
Non-invasive transdermal delivery of chemotherapeutic molecules in vivo using superparamagnetic iron oxide nanoparticles
Author
Vanisri, Raviraj 1 ; Pham Binh T T 2 ; Kim, Byung J 3 ; Pham Nguyen T H 3 ; Kok, Lai F 4 ; Painter, Nicole 3 ; Delic, Naomi C 5 ; Jones, Stephen K 6 ; Hawkett, Brian S 3 ; Guy, Lyons J 7   VIAFID ORCID Logo 

 The University of Sydney, Key Centre for Polymers and Colloids, School of Chemistry, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); The University of Sydney, Dermatology, Sydney Medical School, and Centenary Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
 The University of Sydney, Key Centre for Polymers and Colloids, School of Chemistry, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); The University of Sydney, Northern Clinical School and Kolling Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
 The University of Sydney, Key Centre for Polymers and Colloids, School of Chemistry, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
 Conde S. Januário Hospital, Department of Anatomical Pathology, Macao, China (GRID:grid.460996.4) (ISNI:0000 0004 1798 3082) 
 The University of Sydney, Dermatology, Sydney Medical School, and Centenary Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
 Zeta Therapeutics Pty Ltd, and Sirtex Medical Ltd, Sydney, Australia (GRID:grid.481858.8) (ISNI:0000 0004 6007 6736) 
 The University of Sydney, Dermatology, Sydney Medical School, and Centenary Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); Royal Prince Alfred Hospital, Dermatology, Cancer Services, Sydney, Australia (GRID:grid.413249.9) (ISNI:0000 0004 0385 0051); The University of Sydney, Royal Prince Alfred Hospital, Immune Imaging, Centenary Institute, Camperdown, Australia (GRID:grid.413249.9) 
Publication year
2021
Publication date
Dec 2021
Publisher
Springer Nature B.V.
ISSN
18686958
e-ISSN
18686966
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2486883574
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.